Fangyi Yao

600 total citations
38 papers, 455 citations indexed

About

Fangyi Yao is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Fangyi Yao has authored 38 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Hematology. Recurrent topics in Fangyi Yao's work include RNA modifications and cancer (9 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). Fangyi Yao is often cited by papers focused on RNA modifications and cancer (9 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). Fangyi Yao collaborates with scholars based in China, United States and Taiwan. Fangyi Yao's co-authors include Qing Luo, Junming Li, Zikun Huang, Rigu Su, Jianqing Xu, Xiaozhong Wang, Yiping Peng, Bo Huang, Qing Cheng and Jianqing Ye and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Medicine.

In The Last Decade

Fangyi Yao

35 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangyi Yao China 12 326 259 70 43 39 38 455
Sanjeev Raghuwanshi India 10 398 1.2× 319 1.2× 35 0.5× 22 0.5× 30 0.8× 16 543
Camille Jacques France 12 380 1.2× 165 0.6× 49 0.7× 67 1.6× 105 2.7× 24 545
Ram Babu Undi India 11 200 0.6× 105 0.4× 81 1.2× 25 0.6× 37 0.9× 23 366
Xinlian Chen China 11 304 0.9× 139 0.5× 52 0.7× 25 0.6× 81 2.1× 33 495
Yonghe You China 14 428 1.3× 311 1.2× 77 1.1× 32 0.7× 132 3.4× 23 598
Haiping Zhang China 15 471 1.4× 320 1.2× 50 0.7× 49 1.1× 80 2.1× 36 640
Xingxing Chai China 10 214 0.7× 118 0.5× 65 0.9× 42 1.0× 70 1.8× 27 372

Countries citing papers authored by Fangyi Yao

Since Specialization
Citations

This map shows the geographic impact of Fangyi Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyi Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyi Yao more than expected).

Fields of papers citing papers by Fangyi Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyi Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyi Yao. The network helps show where Fangyi Yao may publish in the future.

Co-authorship network of co-authors of Fangyi Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyi Yao. A scholar is included among the top collaborators of Fangyi Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyi Yao. Fangyi Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Lihua, et al.. (2025). Prognostic value of HSP27 in 28-day mortality in septic ICU patients: a retrospective cohort study. Frontiers in Medicine. 11. 1513788–1513788.
2.
Yao, Fangyi, Ying Cheng, Wen Wen, et al.. (2024). High Expression of SRSF10 Promotes Colorectal Cancer Progression by Aberrant Alternative Splicing of RFC5. Technology in Cancer Research & Treatment. 23. 2234013794–2234013794.
3.
Yao, Fangyi, et al.. (2024). A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma. Technology in Cancer Research & Treatment. 23. 2233974442–2233974442. 1 indexed citations
5.
Yao, Fangyi, et al.. (2024). CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia. Inflammation Research. 73(3). 329–344. 3 indexed citations
6.
Yao, Fangyi, Jing Liu, Ying Cheng, et al.. (2023). Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia. Journal of Translational Medicine. 21(1). 6–6. 4 indexed citations
7.
Yao, Fangyi, Ying Cheng, Jing Liu, et al.. (2023). The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy. Genes & Diseases. 11(2). 993–1008. 7 indexed citations
8.
Yao, Fangyi, Yu‐Lin Yang, Jing Liu, et al.. (2023). Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia. Cancer Cell International. 23(1). 61–61. 7 indexed citations
10.
Zhang, Nan, Xinlu Wang, Kang Wang, et al.. (2023). Hepatic Symbiotic Bacterium L. reuteri FLRE5K1 Inhibits the Development and Progression of Hepatocellular Carcinoma via Activating the IFN-γ/CXCL10/CXCR3 Pathway. Probiotics and Antimicrobial Proteins. 16(4). 1158–1171. 4 indexed citations
11.
Yao, Fangyi, Jing Liu, Haibin Zhang, et al.. (2022). Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia. Frontiers in Oncology. 12. 888570–888570. 14 indexed citations
12.
Yao, Fangyi, Ying Cheng, Jing Liu, et al.. (2022). m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia. Scientific Reports. 12(1). 1759–1759. 21 indexed citations
13.
Zhang, Haibin, Fangyi Yao, Jing Liu, et al.. (2022). A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia. Lipids in Health and Disease. 21(1). 79–79. 8 indexed citations
14.
Yao, Fangyi, Yujie Gao, Biqi Fu, et al.. (2022). Expression and clinical significance of the m6A reader YTHDF2 in peripheral blood mononuclear cells from rheumatoid arthritis patients. Journal of Immunotoxicology. 19(1). 53–60. 14 indexed citations
15.
Yao, Fangyi, et al.. (2021). m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis. Frontiers in Oncology. 11. 679634–679634. 32 indexed citations
16.
Huang, Zikun, Fangyi Yao, Jianqing Xu, et al.. (2018). Microarray Expression Profile of Circular RNAs in Peripheral Blood Mononuclear Cells from Active Tuberculosis Patients. Cellular Physiology and Biochemistry. 45(3). 1230–1240. 62 indexed citations
17.
Huang, Zikun, et al.. (2018). Clinical value of the plasma circular RNA hsa_circ_0009024 in the diagnosis and treatment of pulmonary tuberculosis. Zhonghua jianyan yixue zazhi. 41(5). 399–404. 1 indexed citations
19.
Wang, Yuanzheng, Jiaqi Shen, Qiao Zhou, et al.. (2017). Assessment of left ventricular function in chronic alcoholics by real-time three-dimensional echocardiography. Medicine. 96(5). e6033–e6033. 3 indexed citations
20.
Huang, Zikun, Qing Luo, Fangyi Yao, et al.. (2016). Identification of Differentially Expressed Long Non-coding RNAs in Polarized Macrophages. Scientific Reports. 6(1). 19705–19705. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026